+
Site Tour

One-year Full Cohort Outcomes of TAVI Device for Low and Intermediate Risk Patients: VANTAGE trial

Navitor TAVI gained CE-mark for severe AS in low/intermediate-risk patients, based on the VANTAGE trial; 1-year outcomes from the full cohort are now reported.

Download

LEARN MORE:

TAVI Summit 2026

Related Resources

Transcatheter tricuspid valve repair: Cases, tips and tricks

M-TEER: Best treatment strategies for FMR AND DMR

Latest evidence in patient selection for T-TEER

Echo procedural approach for transcatheter tricuspid repair

M-TEER: State of the art echocardiography imaging modalities

TAVI in complex anatomies

AI-enabled procedural learning

TRENDING TOPICS

TIME TO ACT – Webinar Recordings

REGIONAL ADVANCED HEART FAILURE PATIENT REFERRAL PERSPECTIVES

M-TEER: Best treatment strategies for FMR AND DMR

Mitral Transcatheter Edge to Edge Repair | Best treatment strategies for FMR AND DMR

M-TEER: State of the art echocardiography imaging modalities

State of the art echocardiography imaging modalities | Mitral Transcatheter Edge to Edge Repair

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline